Malaria

Vector-borne diseases including malaria, place an enormous burden on health systems in low- and middle-income countries. Globally, there were an estimated 263 million malaria cases and 597 000 malaria deaths in 83 countries in 2023 (WHO, 2024). In 2023, the WHO African Region accounted for 94% of malaria cases (246 million) and 95% of malaria deaths (569 000). Furthermore, children under the age of five accounted for 76% of all malaria deaths in the region. (WHO, 2024).

Vector Control
Prevention plays a crucial role in malaria control, especially in endemic regions. As a Procurement Services Agent (PSA) for the Global Fund, IDA Foundation supplies insecticide treated nets (ITN), indoor residual spraying (IRS) insecticides and related equipment (e.g. sprayers, PPE) as key vector control interventions to protect vulnerable populations.
In addition, IDA Foundation is at the forefront of supporting the delivery of the latest innovations in vector control, upon obtaining WHO prequalification.

Diagnosis
Early and accurate diagnosis is essential, as misdiagnosis can lead to progressing illness or death. IDA provides rapid diagnostic tests (RDTs), an alternative to microscopy in community settings where it may not be available. 

Treatment
Malaria is treatable with anti-malarial medicines, and the WHO recommends artemisinin-based combination therapy (ACT) for drug-resistant falciparum malaria. IDA offers a full range of antimalarial treatments, including fixed-dose combinations and medicines for severe cases.

You can find our Malaria related products in IDA's Product Indicator. Our extended vector control product list is under development and will be uploaded here in Q2 2025.